Endo's Challenges to Persist in 2019
Although Endo International reported fourth-quarter results ahead of our expectations, its 2019 guidance falls short of our expectations on the bottom line. Our 2019 revenue forecast of $2.9 billion falls within management’s outlook for the year, but the company’s estimate of adjusted EPS of $2-$2.25 is materially short of our prediction, largely from margin compression in the generic injectables business. We don’t anticipate a material change to our fair value estimate since we plan to leave in...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.